| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.46 | 0.006 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |